WillItSurvive
Medical technology and health companies · Israel

Aidoc

aidoc.com ↗

AI software that flags urgent scans like strokes and bleeds for radiologists to review first.

Hard to displace
Assessed 22 July 2026 · Evidence as of 22 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 22 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: FDA decision on First Read generative report drafting, following June 2026 Breakthrough Designation
The call

Aidoc's clearances and hospital integrations protect its core triage business, while report drafting and scanner-embedded rivals test its newer bets.

Aidoc sells software that helps doctors spot problems in medical images like CT scans and X-rays, and it has spent years getting permission from regulators and integrating its tools into hospital computer systems at about 2,000 hospitals. Rivals like GE and Siemens are trying to build similar tools into their own scanning machines, and newer AI companies are competing on the report-writing part of the job, but none of them have yet matched Aidoc's combination of regulatory approvals, legal protections, and deep ties to hospital workflows. The biggest risk is real-world evidence: if studies from more hospitals show that Aidoc actually slows radiologists down or makes errors more likely (two recent studies hinted at this), hospitals will hesitate to buy or expand, even if the software doesn't disappear entirely.

Why
01
AI pressure: DeepHealth (Reporting Pro) and Harrison.ai (Harrison.Rad 1.5). Both now ship AI report-drafting tools that go head to head with Aidoc's new First Read product in the same niche. Could AI do the core job? Unlikely.
02
Bigger players: GE HealthCare, Siemens Healthineers, Philips. These scanner makers are building AI directly into their machines, which could squeeze Aidoc out of single-vendor hospital deals. Could a giant copy it? No, they are blocked.
03
What protects it. Over 30 FDA clearances and live workflow integration in about 2,000 hospitals make Aidoc hard to rip out or copy quickly.
What would change this call
FDA final decision on Aidoc's First Read report-drafting tool within about 6 months of its June 2026 Breakthrough Designation. Would show whether Aidoc can extend its regulatory moat into generative reporting or stalls there.
2 to 3 more academic centers publishing studies replicating UAB's finding that radiologist accuracy fell with Aidoc in place. Would show whether efficacy doubts are hardening into a broader adoption slowdown.
An imaging OEM (GE HealthCare, Siemens Healthineers, or Philips) shipping a cross-vendor triage AI platform. Would show the integration moat is being breached by a scanner-embedded rival.
Key numbers
  • $150M Series E led by Goldman Sachs (2026-04-29)
  • Deployed in about 2,000 hospitals (2026-06-25)
  • UAB study: radiologist accuracy fell with Aidoc in place (2024)
Named risks
  • Independent studies (UAB, 2024) found decreased radiologist accuracy and slower turnaround with Aidoc in place. Severity: high
  • Nature Health (March 2026) links AI-assisted single-read workflows to higher malpractice liability exposure. Severity: medium
  • New entrants DeepHealth and Harrison.ai are shipping competing generative report-drafting tools in 2026. Severity: medium
  • Imaging OEMs (GE, Siemens, Philips) could eventually ship vendor-neutral triage platforms leveraging scanner install base. Severity: medium
  • No audited revenue disclosed; third-party revenue estimates diverge widely, obscuring true financial health. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
GE HealthCare, Siemens Healthineers, PhilipscontestingEmbed proprietary AI into imaging hardware but remain channel-conflicted, no cross-vendor rival shipped as of 2026-07
DeepHealth (RadNet)gaining onLaunched Reporting Pro generative reporting platform July 19, 2026, directly targeting Aidoc's First Read niche
Harrison.aigaining onHarrison.Rad 1.5 report-drafting model noted as new entrant June 26, 2026, competing in report generation
RapidAIcontestingDirectly compared to Aidoc on stroke LVO-detection accuracy in a March 18, 2026 academic scoping review
Questions people ask
Is Aidoc profitable in 2026?
Aidoc is a private company with no audited public revenue figures. It raised a $150M Series E on April 29, 2026 led by Goldman Sachs Alternatives, plus a $40M revolving credit facility, suggesting it is still funding growth rather than confirmed as profitable.
Could AI replace radiologists using Aidoc's tools?
Aidoc's own CEO Elad Walach stated the company aims for a 'pixel to draft report' workflow within two years, via its First Read tool which received FDA Breakthrough Device Designation on June 25, 2026 to draft preliminary chest X-ray report text for radiologist sign-off.
Who owns Aidoc and is it publicly traded?
Aidoc Medical Ltd. is privately held and venture-backed, with no parent company. Investors including Goldman Sachs Alternatives, General Catalyst, SoftBank Vision Fund 2, and NVIDIA's NVentures backed its $150M Series E on April 29, 2026. Aidoc is reportedly weighing an IPO as of April 30, 2026.
Is Aidoc a safe company to join right now?
Aidoc's CEO cited 'over 450 employees' in a May 12, 2026 KFF interview, and the company just closed a $150M Series E on April 29, 2026 with a $40M credit facility, indicating active growth and no reported layoffs as of mid-2026.
Who is Aidoc's biggest competitor?
Aidoc's named structural threat comes from imaging OEMs GE HealthCare, Siemens Healthineers, and Philips, which embed AI directly into scanners but remain channel-conflicted. In the newer report-drafting niche, DeepHealth's Reporting Pro (July 2026) and Harrison.ai's Harrison.Rad 1.5 are direct new entrants.
Is Aidoc's AI triage tool proven to improve radiology accuracy?
Evidence is mixed. A University of Alabama at Birmingham retrospective of nearly 10,000 head CTs, reported in 2024, found radiologist accuracy for brain-bleed detection decreased and turnaround times increased with Aidoc's tool in place; Aidoc disputed the finding as a single-center limitation.
Timeline
  • 2026-07-19DeepHealth (RadNet) launches Reporting Pro, a rival generative radiology reporting platform
  • 2026-06-25Aidoc receives FDA Breakthrough Device Designation for First Read generative report drafting
  • 2026-04-29Aidoc closes $150M Series E led by Goldman Sachs Alternatives, plus $40M credit facility
  • 2026-04-24Aidoc raises $150M for CARE foundation model with health systems as strategic investors
  • 2026-03-10Nature Health study links AI-assisted single-read radiology workflows to higher malpractice liability
  • 2026-01-21FDA clears Aidoc's comprehensive multi-condition AI triage solution, 11 new indications
  • 2025-09Aidoc receives FDA Breakthrough Device Designation for CARE Triage multi-condition CT solution
  • 2024-10Aidoc partners with NVIDIA on BRIDGE framework for healthcare AI deployment
  • 2024-09-05UAB retrospective study reports Aidoc tool linked to decreased radiologist accuracy, slower turnaround
Revision history
22 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Epic SystemsPro MedicusCochlear Limited
More in Medical technology and health companies →
Sources